ad
This Article
Right arrow Images Only
Right arrow Full Version
Services
Right arrow E-mail this link to a friend
Right arrow Related text in Red Book
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Articles in Pediatrics
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices

The first 300 words of the full text of this section appear below.

Section 3. Summaries of Infectious Diseases

Pertussis (Whooping Cough)

Clinical Manifestations
Etiology
Epidemiology
Diagnostic Tests
Treatment
Isolation of the Hospitalized Patient
Control Measures

Top
 Next
See Images

CLINICAL MANIFESTATIONS

Pertussis begins with mild upper respiratory tract symptoms similar to the common cold (catarrhal stage) and progresses to cough and then usually to paroxysms of cough (paroxysmal stage) characterized by inspiratory whoop and commonly followed by vomiting. Fever is absent or minimal. Symptoms wane gradually over weeks to months (convalescent stage). Disease in infants younger than 6 months of age can be atypical with a short catarrhal stage, gagging, gasping, or apnea as prominent early manifestations; absence of whoop; and prolonged convalescence. Sudden unexpected death can be caused by pertussis. Cough illness in immunized children and adults can be mild and unrecognized. The duration of classic pertussis is 6 to 10 weeks. Approximately one half of adolescents with pertussis cough for 10 weeks or longer. Complications among adolescents and adults include syncope, sleep disturbance, incontinence, rib fractures, and pneumonia. Pertussis is most severe when it occurs during the first 6 months of life, particularly in preterm and unimmunized infants. Complications among infants include pneumonia (22%), seizures (2%), encephalopathy (less than 0.5%), and death. Case-fatality rates are approximately 1% in infants younger than 2 months of age and less than 0.5% in infants 2 through 11 months of age.


Top
 Previous
Next
See Images

ETIOLOGY

Pertussis is caused by a fastidious, gram-negative, pleomorphic bacillus, Bordetella pertussis. Other causes of sporadic prolonged cough illness include Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia trachomatis, Chlamydophila pneumoniae, Bordetella bronchiseptica, and certain respiratory tract viruses, particularly adenoviruses and respiratory syncytial viruses.


Top
 Previous
Next
See Images

EPIDEMIOLOGY

Humans are the only known hosts of B pertussis. Transmission occurs by close contact with cases via aerosolized droplets. Neither infection nor immunization provides lifelong immunity. Lack of natural booster events and . . . [Go to Full Text]


Related text in Red Book:

Summary of Major Changes in the 2009 Red Book

Red Book 2009: XXIX. [Extract] [Full Version]  

Lapsed Immunizations

Red Book 2009: 34. [Extract] [Full Version]  

Unknown or Uncertain Immunization Status

Red Book 2009: 35-36. [Extract] [Full Version]  

Reporting of Adverse Events

Red Book 2009: 42-51. [Extract] [Full Version]  

Scheduling Immunizations

Red Book 2009: 21-31. [Extract] [Full Version]  

Interchangeability of Vaccine Products

Red Book 2009: 32-33. [Extract] [Full Version]  

Simultaneous Administration of Multiple Vaccines

Red Book 2009: 33-34. [Extract] [Full Version]  

Preterm and Low Birth Weight Infants

Red Book 2009: 68-70. [Extract] [Full Version]  

Health Care Personnel

Red Book 2009: 94-97. [Extract] [Full Version]  

Pregnancy

Red Book 2009: 70-72. [Extract] [Full Version]  

Children With a Personal or Family History of Seizures

Red Book 2009: 86. [Extract] [Full Version]  

Children in Residential Institutions

Red Book 2009: 90-92. [Extract] [Full Version]  

Immunizations

Red Book 2009: 183-184. [Extract] [Full Version]  

Recommendations for Inclusion or Exclusion

Red Book 2009: 127-131. [Extract] [Full Version]  

Infectious Diseases—Epidemiology and Control

Red Book 2009: 131-138. [Extract] [Full Version]  

Infections Spread by the Respiratory Route

Red Book 2009: 142-143. [Extract] [Full Version]  

Tetanus (Lockjaw)

Red Book 2009: 655-660. [Extract] [Full Version]  

Diphtheria

Red Book 2009: 280-283. [Extract] [Full Version]  

Haemophilus influenzae Infections

Red Book 2009: 314-321. [Extract] [Full Version]  

Hepatitis B

Red Book 2009: 337-356. [Extract] [Full Version]  

MedWatch—The FDA Safety Information and Adverse Event Reporting Program

Red Book 2009: 817-818. [Extract] [Full Version]  

Principles of Appropriate Use for Upper Respiratory Tract Infections

Red Book 2009: 740-742. [Extract] [Full Version]  



This topic has been referenced by these articles:

  • Arnold, J. C., Singh, K. K., Spector, S. A., Sawyer, M. H. (2008). Undiagnosed Respiratory Viruses in Children. Pediatrics 121: e631-e637 [Abstract] [Full Version]  
  • Groom, A. V., Washington, M. L., Smith, P. J., Bryan, R. T. (2008). Underimmunization of American Indian and Alaska Native Children. Pediatrics 121: 938-944 [Abstract] [Full Version]  
  • Marshall, H. S., Gold, M. S., Gent, R., Quinn, P. J., Piotto, L., Clarke, M. F., Roberton, D. M. (2006). Ultrasound Examination of Extensive Limb Swelling Reactions After Diphtheria-Tetanus-Acellular Pertussis or Reduced-Antigen Content Diphtheria-Tetanus-Acellular Pertussis Immunization in Preschool-Aged Children. Pediatrics 118: 1501-1509 [Abstract] [Full Version]  
  • Enriquez, R., Persky, V., Hartert, T. (2007). Trends in Asthma Prevalence and Recommended Number of Childhood Immunizations Are Not Parallel. Pediatrics 119: 222-223 [Full Version]  
  • Braun, M. M. (2008). Toward Better Vaccine Safety Data and Safer Vaccination. Pediatrics 121: 625-626 [Full Version]  
  • Allred, N. J., Wooten, K. G., Kong, Y. (2007). The Association of Health Insurance and Continuous Primary Care in the Medical Home on Vaccination Coverage for 19- to 35-Month-Old Children. Pediatrics 119: S4-S11 [Abstract] [Full Version]  
  • Guerra, F. A., Blatter, M. M., Greenberg, D. P., Pichichero, M., Noriega, F. R., on behalf of the Pentacel Study Group, (2009). Safety and Immunogenicity of a Pentavalent Vaccine Compared With Separate Administration of Licensed Equivalent Vaccines in US Infants and Toddlers and Persistence of Antibodies Before a Preschool Booster Dose: A Randomized, Clinical Trial. Pediatrics 123: 301-312 [Abstract] [Full Version]  
  • Spycher, B. D., Silverman, M., Egger, M., Zwahlen, M., Kuehni, C. E. (2009). Routine Vaccination Against Pertussis and the Risk of Childhood Asthma: A Population-Based Cohort Study. Pediatrics 123: 944-950 [Abstract] [Full Version]  
  • Ward, K. N., Bryant, N. J., Andrews, N. J., Bowley, J. S., Ohrling, A., Verity, C. M., Ross, E. M., Miller, E. (2007). Risk of Serious Neurologic Disease After Immunization of Young Children in Britain and Ireland. Pediatrics 120: 314-321 [Abstract] [Full Version]  
  • Weinberger, M., Abu-Hasan, M. (2007). Pseudo-asthma: When Cough, Wheezing, and Dyspnea Are Not Asthma. Pediatrics 120: 855-864 [Abstract] [Full Version]  
  • Jackson, L. A., Starkovich, P., Dunstan, M., Yu, O., Nelson, J., Dunn, J., Rees, T., Zavitkovsky, A., Maus, D., Froeschle, J. E., Decker, M. (2008). Prospective Assessment of the Effect of Needle Length and Injection Site on the Risk of Local Reactions to the Fifth Diphtheria-Tetanus-Acellular Pertussis Vaccination. Pediatrics 121: e646-e652 [Abstract] [Full Version]  
  • Ortega-Sanchez, I. R., Lee, G. M., Jacobs, R. J., Prosser, L. A., Molinari, N.-A., Zhang, X., Baine, W. B., McCauley, M. M., Miller, T., for the Working Group on Leading Economic Issues f, (2008). Projected Cost-effectiveness of New Vaccines for Adolescents in the United States. Pediatrics 121: S63-S78 [Abstract] [Full Version]  
  • Shinall, M. C. Jr, Peters, T. R., Zhu, Y., Chen, Q., Poehling, K. A. (2008). Potential Impact of Acceleration of the Pertussis Vaccine Primary Series for Infants. Pediatrics 122: 1021-1026 [Abstract] [Full Version]  
  • Cortese, M. M., Baughman, A. L., Zhang, R., Srivastava, P. U., Wallace, G. S. (2008). Pertussis Hospitalizations Among Infants in the United States, 1993 to 2004. Pediatrics 121: 484-492 [Abstract] [Full Version]  
  • Abzug, M. J., Song, L.-Y., Fenton, T., Nachman, S. A., Levin, M. J., Rosenblatt, H. M., Pelton, S. I., Borkowsky, W., Edwards, K. M., Peters, J., for the International Maternal Pediatric Adolescen, (2007). Pertussis Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy. Pediatrics 120: e1190-e1202 [Abstract] [Full Version]  
  • Glanz, J. M., McClure, D. L., Magid, D. J., Daley, M. F., France, E. K., Salmon, D. A., Hambidge, S. J. (2009). Parental Refusal of Pertussis Vaccination Is Associated With an Increased Risk of Pertussis Infection in Children. Pediatrics 123: 1446-1451 [Abstract] [Full Version]  
  • Fishbein, D. B., Broder, K. R., Markowitz, L., Messonnier, N. (2008). New, and Some Not-so-New, Vaccines for Adolescents and Diseases They Prevent. Pediatrics 121: S5-S14 [Abstract] [Full Version]  
  • Offit, P. A. (2008). New Book About Vaccine Safety. Pediatrics 122: 871-872 [Full Version]  
  • Daskalaki, I., Long, S. S., Watson, B., Chilton, L. (2009). New Advisory Committee on Immunization Practices Guidelines for Rotavirus Vaccine Allow More Children to Receive Vaccine. Pediatrics 123: e174-e175 [Full Version]  
  • Tozzi, A. E., Bisiacchi, P., Tarantino, V., De Mei, B., D'Elia, L., Chiarotti, F., Salmaso, S. (2009). Neuropsychological Performance 10 Years After Immunization in Infancy With Thimerosal-Containing Vaccines. Pediatrics 123: 475-482 [Abstract] [Full Version]  
  • Kim, J. S., Sun Jo, D., Go, U., Park, B. H., Cho, H., Oh, D.-K. (2008). NATIONAL VACCINE INJURY COMPENSATION PROGRAM IN KOREA: A 12-YEAR EXPERIENCE. Pediatrics 121: S165-S165 [Abstract]  
  • Gustafsson, L., Hessel, L., Storsaeter, J., Olin, P. (2006). Long-term Follow-up of Swedish Children Vaccinated With Acellular Pertussis Vaccines at 3, 5, and 12 Months of Age Indicates the Need for a Booster Dose at 5 to 7 Years of Age. Pediatrics 118: 978-984 [Abstract] [Full Version]  
  • Balicer, R. D., Grotto, I., Mimouni, M., Mimouni, D. (2007). Is Childhood Vaccination Associated With Asthma? A Meta-analysis of Observational Studies. Pediatrics 120: e1269-e1277 [Abstract] [Full Version]  
  • McCauley, M. M., Fishbein, D. B., Santoli, J. M. (2008). Introduction: Strengthening the Delivery of New Vaccines for Adolescents. Pediatrics 121: S1-S4 [Full Version]  
  • Daskalaki, I., Spain, C. V., Long, S. S., Watson, B. (2008). Implementation of Rotavirus Immunization in Philadelphia, Pennsylvania: High Levels of Vaccine Ineligibility and Off-Label Use. Pediatrics 122: e33-e38 [Abstract] [Full Version]  
  • Nolan, T., Bernstein, H., Blatter, M. M., Bromberg, K., Guerra, F., Kennedy, W., Pichichero, M., Senders, S. D., Trofa, A., Collard, A., Sullivan, D. C., Descamps, D. (2006). Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine Administered Concomitantly With Diphtheria-Tetanus-Acellular Pertussis and Haemophilus influenzae Type B Vaccines to Children Less Than 2 Years of Age. Pediatrics 118: e602-e609 [Abstract] [Full Version]  
  • Batra, J. S., Eriksen, E. M., Zangwill, K. M., Lee, M., Marcy, S. M., Ward, J. I., for the Vaccine Safety Datalink, (2009). Evaluation of Vaccine Coverage for Low Birth Weight Infants During the First Year of Life in a Large Managed Care Population. Pediatrics 123: 951-958 [Abstract] [Full Version]  
  • (2009). ERRATUM. Pediatrics 123: 1437-1437 [Full Version]  
  • Kummeling, I., Thijs, C., Stelma, F., Huber, M., van den Brandt, P. A., Dagnelie, P. C. (2007). Diphtheria, Pertussis, Poliomyelitis, Tetanus, and Haemophilus influenzae Type b Vaccinations and Risk of Eczema and Recurrent Wheeze in the First Year of Life: The KOALA Birth Cohort Study. Pediatrics 119: e367-e373 [Abstract] [Full Version]  
  • Mansbach, J. M., Camargo, C. A. Jr (2008). Bronchiolitis: Lingering Questions About Its Definition and the Potential Role of Vitamin D. Pediatrics 122: 177-179 [Full Version]  
  • Smith, P. J., Kennedy, A. M., Wooten, K., Gust, D. A., Pickering, L. K. (2006). Association Between Health Care Providers' Influence on Parents Who Have Concerns About Vaccine Safety and Vaccination Coverage. Pediatrics 118: e1287-e1292 [Abstract] [Full Version]  
  • Hatfield, L. A., Gusic, M. E., Dyer, A.-M., Polomano, R. C. (2008). Analgesic Properties of Oral Sucrose During Routine Immunizations at 2 and 4 Months of Age. Pediatrics 121: e327-e334 [Abstract] [Full Version]  
  • Dylag, A. M., Shah, S. I. (2008). Administration of Tetanus, Diphtheria, and Acellular Pertussis Vaccine to Parents of High-Risk Infants in the Neonatal Intensive Care Unit. Pediatrics 122: e550-e555 [Abstract] [Full Version]  
  • Carbone, T., McEntire, B., Kissin, D., Kelly, D., Steinschneider, A., Violaris, K., Karamchandani, N. (2008). Absence of an Increase in Cardiorespiratory Events After Diphtheria-Tetanus-Acellular Pertussis Immunization in Preterm Infants: A Randomized, Multicenter Study. Pediatrics 121: e1085-e1090 [Abstract] [Full Version]  
  • Zangwill, K. M., Eriksen, E., Lee, M., Lee, J., Marcy, S. M., Friedland, L. R., Weston, W., Howe, B., Ward, J. I. (2008). A Population-Based, Postlicensure Evaluation of the Safety of a Combination Diphtheria, Tetanus, Acellular Pertussis, Hepatitis B, and Inactivated Poliovirus Vaccine in a Large Managed Care Organization. Pediatrics 122: e1179-e1185 [Abstract] [Full Version]  
  • Daley, M. F., Liddon, N., Crane, L. A., Beaty, B. L., Barrow, J., Babbel, C., Markowitz, L. E., Dunne, E. F., Stokley, S., Dickinson, L. M., Berman, S., Kempe, A. (2006). A National Survey of Pediatrician Knowledge and Attitudes Regarding Human Papillomavirus Vaccination. Pediatrics 118: 2280-2289 [Abstract] [Full Version]